What Can Embryo Testing Tell You Before a Transfer?
An offer to test embryos can sound as though it will answer every question about a future pregnancy. In practice, preimplantation genetic testing covers different tests with different purposes. Before deciding, ask which question the proposed test can address, how the result could change treatment and what uncertainty would remain afterwards.
Identify the specific question being investigated
PGT-M looks for a particular inherited condition associated with a known gene change. PGT-SR is used in the context of a known structural chromosome rearrangement, where embryos may inherit missing or extra chromosome material. These tests can help identify embryos for transfer that are not affected by the condition or imbalance being investigated; they do not check for every possible health condition.
PGT-A assesses chromosome number and is commonly discussed as a way to help select embryos for transfer. It does not replace targeted testing for a known inherited condition. Ask the team to name the proposed test clearly and explain why it is relevant to your history instead of treating all embryo testing as one interchangeable service.
Include genetic counselling in the decision
A suitably qualified genetics professional can review your family history and existing reports, explain inheritance and discuss the available options. Check who provides this advice and whether the laboratory has relevant experience with the specific test. For targeted testing, additional family samples or preparatory work may be needed before an embryo can be analysed.
Discuss what you would want to know and how different findings might affect your choices. Some results can be uncertain or require a more detailed interpretation than a simple positive or negative label suggests. Having that conversation before treatment provides more time to consider decisions that may otherwise feel urgent when results arrive.
Consider the treatment required to obtain a result
Embryo testing takes place within an IVF pathway, including for people who do not otherwise have difficulty conceiving. Ask how the proposed testing affects the sequence of treatment, whether embryos will be frozen and when a transfer might be considered. The estimate should explain testing, storage and any later transfer costs separately.
There are risks associated with IVF, including ovarian hyperstimulation, and removing cells for testing can damage an embryo. Not every embryo will reach the stage at which it can be tested, and a cycle may end without an embryo suitable for transfer. The discussion should cover those possibilities alongside the information testing might provide.
Understand how the result could limit your options
Tests are not perfectly accurate, and some produce an inconclusive result. PGT-A may also report a mosaic finding, suggesting a mixture of cells with different chromosome results in the sample. Its implications need specialist interpretation; the result should not be reduced to an assumption that the whole embryo has been characterised with certainty.
Ask about the clinic’s policies for reviewing uncertain results and making decisions about storage or transfer. PGT-A does not create additional embryos, and its value as a routine test to improve the chance of a baby for every IVF patient has not been established. Any proposed benefit needs to be considered against your circumstances, the available embryos and the consequences of excluding one from use.
Keep follow-up care in the plan
Arrange a results consultation with time to discuss the report rather than relying on a brief message. If treatment proceeds, obtain the usual recovery and follow-up instructions from the fertility team, including whom to contact with concerns. Keep copies of the genetic reports for the professionals who will provide subsequent care.
A pregnancy after testing still needs antenatal care and a discussion of prenatal screening or diagnostic testing. An embryo result cannot exclude every genetic or developmental condition, and confirmatory testing may be offered depending on the circumstances. Ask how the fertility and maternity teams will communicate the relevant information.
Understanding the limits of chromosome screening is part of deciding whether it addresses your needs; targeted testing for a known inherited condition answers a different question. A sound decision brings the purpose, possible results and follow-up together, with room for individual preferences and no promise of a guaranteed pregnancy or healthy child.
